Advertisement

Brain-type Natriuretic Peptide Levels and Invasive Hemodynamic Parameters in Dialysis Dependent Patients

Published:September 21, 2022DOI:https://doi.org/10.1016/j.amjms.2022.04.035

      Abstract

      Background

      Pulmonary hypertension (PH) is associated with increased mortality in patients with end-stage renal disease (ESRD). The prevalence of PH within ESRD as measured by right heart catheterization (RHC) is poorly described, and the correlation of BNP to pulmonary artery pressure (PAP) is unknown.

      Methods

      The renal transplant database at our center was used to identify adult ESRD patients from July 2013 to July 2015 who had a plasma BNP level measurement and invasive hemodynamic assessment by RHC within a 1-month period. Pulmonary hypertension was defined as a mean pulmonary artery pressure (PAP) ≥ 25 mmHg. Multivariate linear regression analysis was used to identify correlations between BNP and RHC parameters. To estimate the utility of BNP in the screening of PH, a receiver-operating characteristic (ROC) curve was generated.

      Results

      Eighty-eight patients were included in the study of which 43 had PH. Compared to patients without PH, BNP was significantly higher within the PH cohort (1619 ± 2602 pg/ml vs. 352 ± 491 pg/ml). A statistically significant association (r [86] = 0.60, p<0.001) between plasma BNP and mean PAP was identified. ROC curve indicated an acceptable predictive value of BNP in PH with a c-statistic of 0.800 (95% CI 0.708 – 0.892).

      Conclusions

      In ESRD patients being considered for renal transplantation, PH is highly prevalent and BNP levels are elevated and significantly correlated with higher PAP. BNP may be a useful non-invasive marker of PH in these patients.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Yigla M
        • Fruchter O
        • Aharonson D
        • et al.
        Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients.
        Kidney Int. 2009; 75: 969-975
        • Schoenberg NC
        • Argula RG
        • Klings ES
        • Wilson KC
        • Farber HW.
        Prevalence and Mortality of Pulmonary Hypertension in ESRD: A Systematic Review and Meta-analysis.
        Lung. 2020; : 1-11
        • Abdelwhab S
        • Elshinnawy S.
        Pulmonary hypertension in chronic renal failure patients.
        Am J Nephrol. 2008; 28: 990-997
      1. Bozbas S, Akcay S, Altin C, et al. Pulmonary hypertension in patients with end-stage renal disease undergoing renal transplantation. Paper presented at: Transplantation proceedings2009.

        • Pabst S
        • Hammerstingl C
        • Hundt F
        • et al.
        Pulmonary hypertension in patients with chronic kidney disease on dialysis and without dialysis: results of the PEPPER-study.
        PLoS One. 2012; 7: e35310
        • El-Korashy R
        • Amin Y
        • Eissa A
        • Thabet T.
        Echocardiography versus right heart catheterization in class I pulmonary hypertension.
        Egyptian Journal of Chest Diseases and Tuberculosis. 2014; 63: 419-422
        • Gazda AJ
        • Aponte MMP
        • De Golovine A
        • Edwards A
        • Pai A
        • Akkanti BH.
        A crossroads at the understanding of pulmonary hypertension in end stage renal disease. Heart & lung: the journal of critical care. 2021; 50: 232-233
        • Cavagna L
        • Caporali R
        • Klersy C
        • et al.
        Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.
        The Journal of rheumatology. 2010; 37: 2064-2070
        • Helgeson SA
        • Imam JS
        • Moss JE
        • Hodge DO
        • Burger CD.
        Comparison of brain natriuretic peptide levels to simultaneously obtained right heart hemodynamics in stable outpatients with pulmonary arterial hypertension.
        Diseases. 2018; 6: 33
      2. Moza A, Khan AR, Parashar R, et al. Pulmonary hypertension in renal transplant candidates: A systematic review and meta-analysis of the available evidence and a proposed algorithm for pre-transplant management. 2017.

        • O'Leary JM
        • Assad TR
        • Xu M
        • et al.
        Lack of a tricuspid regurgitation Doppler signal and pulmonary hypertension by invasive measurement.
        Journal of the American Heart Association. 2018; 7e009362
        • O'Leary JM
        • Assad TR
        • Xu M
        • et al.
        Pulmonary hypertension in patients with chronic kidney disease: invasive hemodynamic etiology and outcomes. Pulmonary circulation. 2017; 7: 674-683
        • Edmonston DL
        • Parikh KS
        • Rajagopal S
        • et al.
        Pulmonary hypertension subtypes and mortality in CKD.
        Am J Kidney Dis. 2020; 75: 713-724
        • Maddipati V
        • Chakinala M.
        Pulmonary Hypertension in Chronic Kidney Disease and End-Stage Renal Disease.
        Pulmonary Hypertension. Springer. 2020; : 173-194